These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11226414)

  • 1. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis.
    Jakubowski H; Ambrosius WT; Pratt JH
    FEBS Lett; 2001 Feb; 491(1-2):35-9. PubMed ID: 11226414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
    Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
    Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
    Perla-Kaján J; Jakubowski H
    FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation.
    Jakubowski H
    J Biol Chem; 2000 Feb; 275(6):3957-62. PubMed ID: 10660550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status.
    Domagała TB; Łacinski M; Trzeciak WH; Mackness B; Mackness MI; Jakubowski H
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(5):4-10. PubMed ID: 17543199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein N-homocysteinylation: implications for atherosclerosis.
    Jakubowski H
    Biomed Pharmacother; 2001 Oct; 55(8):443-7. PubMed ID: 11686577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase 1 and homocysteine metabolism.
    Perła-Kaján J; Jakubowski H
    Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of paraoxonase 1 and protein N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat.
    Beltowski J; Wójcicka G; Jakubowski H
    J Endocrinol; 2010 Feb; 204(2):191-8. PubMed ID: 19887391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
    Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay.
    Kosaka T; Yamaguchi M; Motomura T; Mizuno K
    Clin Chim Acta; 2005 Sep; 359(1-2):156-62. PubMed ID: 15927175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1.
    Borowczyk K; Shih DM; Jakubowski H
    J Alzheimers Dis; 2012; 30(2):225-31. PubMed ID: 22406444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans.
    Jakubowski H
    Clin Chem Lab Med; 2003 Nov; 41(11):1462-6. PubMed ID: 14656026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase gene polymorphisms and coronary reactivity in young healthy men.
    Malin R; Knuuti J; Janatuinen T; Laaksonen R; Vesalainen R; Nuutila P; Jokela H; Laakso J; Jaakkola O; Solakivi T; Lehtimäki T
    J Mol Med (Berl); 2001 Aug; 79(8):449-58. PubMed ID: 11511975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.
    Jakubowski H
    Adv Exp Med Biol; 2010; 660():113-27. PubMed ID: 20221875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
    Ferretti G; Bacchetti T; Marotti E; Curatola G
    Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans.
    Perła-Kaján J; Borowczyk K; Głowacki R; Nygård O; Jakubowski H
    FASEB J; 2018 May; ():fj201800346R. PubMed ID: 29782204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative method for the assessment of homocysteine thiolactonase enzyme activity.
    Obeid NJ; Hadwan MH
    Anal Biochem; 2021 Oct; 631():114365. PubMed ID: 34506754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes.
    Weijun G; Juming L; Guoqing Y; Jingtao D; Qinghua G; Yiming M; Changyu P
    Adv Ther; 2008 Sep; 25(9):884-93. PubMed ID: 18781288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease.
    Parada-Turska J; Wójcicka G; Beltowski J
    Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase.
    Zimny J; Sikora M; Guranowski A; Jakubowski H
    J Biol Chem; 2006 Aug; 281(32):22485-92. PubMed ID: 16769724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.